BEHAVIOURAL TREATMENT OF OBSESSIVE COMPULSIVE DISORDER

2000 ◽  
Vol 28 (4) ◽  
pp. 353-360 ◽  
Author(s):  
Karen Rowa ◽  
Martin M. Antony ◽  
Richard P. Swinson

Until the late 1960s, obsessive compulsive disorder (OCD) was considered to be a relatively untreatable condition. Over the next several years, many advances were made in the psychological treatment of OCD as clinicians and researchers began to realize the value of behavioural treatments for this population. Isaac Marks and his colleagues played an instrumental role in the development and initial validation of exposure-based treatments for OCD. In addition to his other important research in the area of anxiety, Marks continued to study behavioural treatments for OCD, including the processes and predictors of treatment outcome. More recently, his work has focused on self-administered treatments for OCD and other anxiety disorders, including computerized and telephone-based treatments. This paper reviews research on the behavioural treatment of OCD, with an emphasis on the contributions of Isaac Marks.

2010 ◽  
Vol 27 (4) ◽  
pp. 365-371 ◽  
Author(s):  
Christopher A. Flessner ◽  
Amy Allgair ◽  
Abbe Garcia ◽  
Jennifer Freeman ◽  
Jeffrey Sapyta ◽  
...  

2014 ◽  
Vol 28 (3) ◽  
pp. 287-298 ◽  
Author(s):  
Johanna Thompson-Hollands ◽  
Aubrey Edson ◽  
Martha C. Tompson ◽  
Jonathan S. Comer

2005 ◽  
Vol 19 (4) ◽  
pp. 317-330 ◽  
Author(s):  
Martin E. Franklin ◽  
H. Blair Simpson

The efficacy of cognitive-behavioral therapy (CBT) involving exposure and ritual prevention (EX/RP) for obsessive compulsive disorder (OCD) has been well documented, as has the efficacy of pharmacotherapy using serotonin reuptake inhibitors (SRIs). Response to these monotherapies is neither universal nor complete, however, and in the past 20 years significant progress has been made in examining the efficacy of combined EX/RP plus SRI treatment. Results of randomized controlled trials that have employed adequate methodology suggest that combined treatment may afford some advantages over the monotherapies, although the effect is generally not robust and there are some negative findings. Combined treatment may be especially useful in certain clinical circumstances, however, and case examples are provided describing the use of combined treatment for one patient who presented with comorbid depression and for another who refused EX/RP because he perceived it as too threatening.


Sign in / Sign up

Export Citation Format

Share Document